Liver functional reserve estimation: State of the art and relevance for local treatments. The Western perspective

Journal of Hepato-Biliary-Pancreatic Sciences

Volumn 17, Issue 4, 2010, Pages 385-388

  Manizate, Fotini ^a   Hiotis, Spiros P ^a   Labow, Daniel ^a   Roayaie, Sasan ^a   Schwartz, Myron ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Hepatic reserve; Hepatocellular carcinoma; Liver function; Liver resection

Indexed keywords

CANCER ADJUVANT THERAPY; CANCER RISK; CHEMOEMBOLIZATION; HEPATITIS; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FUNCTION TEST; LIVER RESECTION; LIVER TRANSPLANTATION; QUANTITATIVE STUDY; RADIOFREQUENCY ABLATION; REVIEW; RISK FACTOR; SCORING SYSTEM; TUMOR RECURRENCE; UNITED STATES; ADJUVANT THERAPY; HOSPITALIZATION; LIVER TUMOR; METABOLISM; METHODOLOGY; REPRODUCIBILITY;

COLORING AGENT; DIAGNOSTIC AGENT; INDOCYANINE GREEN;

CARCINOMA, HEPATOCELLULAR; COLORING AGENTS; HEPATECTOMY; HUMANS; INDOCYANINE GREEN; LIVER FUNCTION TESTS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; NEOADJUVANT THERAPY; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; UNITED STATES;

EID: 79952110055     PISSN: 18686974     EISSN: 18686982     Source Type: Journal    
DOI: 10.1007/s00534-009-0228-x     Document Type: Review

References (13)

1. Schwartz M, Roayaie S, Konstadoulakis M. Strategies for the management of hepatocellular carcinoma. Nat Clin Pract Oncol. 2007;4:424-32. (Pubitemid 47039693)
2. Llovet JM, Schwartz M, Mazzaferro V. Resection and liver transplantation for hepatocellular carcinoma. Semin Liver Dis. 2005;25:181-200. (Pubitemid 40781071)
3. Abulkhir A, Limongelli P, Healey AJ, Damrah O, Tait P, Jackson J, et al. Preoperative portal vein embolization for major liver resection: a meta-analysis. Ann Surg. 2008;247:49-57.
4. Delis SG, Bakoyiannis A, Tassopoulos N, Athanasiou K, Madariaga J, Dervenis C. Radiofrequency-assisted liver resection. Surg Oncol. 2008;17:81-6. (Pubitemid 351508400)
5. Delis SG, Madariaga J, Bakoyiannis A, Dervenis Ch. Current role of bloodless liver resection. World J Gastroenterol. 2007;13:826-9.
6. Ng KK, Poon RT, Lo CM, Yuen J, Tso WK, Fan ST. Analysis of recurrence pattern and its influence on survival outcome after radiofrequency ablation of hepatocellular carcinoma. Gastrointest Surg. 2008;12(1):183-91. Epub 2007 Sep 15.
7. Livraghi T, Meloni F, Di Stasi M, Rolle E, Solbiati L, Tinelli C, et al. Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice? Hepatology. 2008;47(1):82-9.
8. Mazzaferro V, Battiston C, Perrone S, Pulvirenti A, Regalia E, Romito R, et al. Radiofrequency ablation of small hepatocellular carcinoma in cirrhotic patients awaiting liver transplantation: a prospective study. Ann Surg. 2004;240(5):900-9. (Pubitemid 39425785)
9. Liaw YF, Sung JJ, Chow WC, Farrell G, Lee CZ, Yuen H, et al. Lamivudine for patients with chronic hepatitis B and advanced liver disease. N Engl J Med. 2004;351(15):1521-31.
10. Mazzaferro V, Romito R, Schiavo M, Mariani L, Camerini T, Bhoori S, et al. Prevention of hepatocellular carcinoma recurrence with alpha-interferon after liver resection in HCV cirrhosis. Hepatology. 2006;44(6):1543-54. (Pubitemid 44970357)
11. Yang HI, Yeh SH, Chen PJ, Iloeje UH, Jen CL, Su J, et al. Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma. J Natl Cancer Inst. 2008;100(16):1134-43. Epub 2008 Aug 11.
12. Lok AS, Seeff LB, Morgan TR, di Bisceglie AM, Sterling RK, Curto TM, et al. Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease. Gastroenterology. 2009;136(1):138-48. Epub 2008 Sep 18.
13. Hoshida Y, Villanueva A, Kobayashi M, Peix J, Chiang DY, Camargo A, et al. Gene expression in fixed tissues and outcome in hepatocellular carcinoma. N Engl J Med. 2008;359(19):1995-2004. Epub 2008 Oct 15.